← Back to Clinical Trials
Recruiting NCT07068412

NCT07068412 Impact of 3D-Printed Anatomical Model on Patient Understanding in Orthognathic Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07068412
Status Recruiting
Phase
Sponsor King Abdulaziz University
Condition Skeletal Deformities
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-06-01
Primary Completion 2025-08-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
3D-printed Orthognathic Surgical Simulation2D Visual Representations of Skeletal Movements in Orthognathic Surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-06-01 with a primary completion date of 2025-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn whether using three dimensional (3D)-printed anatomical models improves the informed consent process for participants undergoing orthognathic surgery. The trial also explores how these models affect participants understanding, anxiety, satisfaction, and communication with the surgeon. The main questions it aims to answer are: * Do 3D-printed anatomical models improve participants understanding of their jaw condition and the surgical procedure? * Do they reduce participants anxiety before surgery? * Do they enhance overall participants satisfaction and the physician-patient relationship? Researchers compares participants who received standard two dimensional (2D) imaging and verbal explanations with those who received the same information plus 3D-printed jaw models. Participants: * Scheduled for double- or triple-jaw orthognathic surgery * Randomly assigned to receive either traditional 2D education or the 3D-printed model intervention * Complete a validated questionnaires assessing understanding, anxiety, satisfaction, and doctor-patient communication

Eligibility Criteria

Inclusion Criteria: * Adult patients (aged 18 and above) * Scheduled for orthognathic surgery (specifically double-jaw or triple-jaw procedures) Exclusion Criteria: * Pediatric patients (under 18 years old) * Patients undergoing re-do/revision surgery * Patients with psychiatric disorders * Patients receiving only orthodontic treatment * Patients undergoing single-jaw surgery

Contact & Investigator

Central Contact

Razan M Baabdullah, BDS,MS,FRCDC

✉ rmsbaabdullah@kau.edu.sa

📞 +96655501567

Principal Investigator

Razan M Baabdullah, BDS,MS,FRCDC

PRINCIPAL INVESTIGATOR

King Abdulaziz University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery

Frequently Asked Questions

Who can join the NCT07068412 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Skeletal Deformities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07068412 currently recruiting?

Yes, NCT07068412 is actively recruiting participants. Contact the research team at rmsbaabdullah@kau.edu.sa for enrollment information.

Where is the NCT07068412 trial being conducted?

This trial is being conducted at Jeddah, Saudi Arabia, Jeddah, Saudi Arabia.

Who is sponsoring the NCT07068412 clinical trial?

NCT07068412 is sponsored by King Abdulaziz University. The principal investigator is Razan M Baabdullah, BDS,MS,FRCDC at King Abdulaziz University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology